[Featured Stock] PharmaResearch Hits 52-Week High on Export Growth Expectations Fueled by Rejuran

Pharmaresearch's stock price is on the rise. The expectation of export growth in other business divisions due to the brand awareness of Rejuran appears to be influencing the stock price.

At 9:32 AM on the 14th, Pharmaresearch was trading at 180,000 KRW, up 4.47% from the previous day.

Jeong Heeryeong, a researcher at Shinhan Investment Corp., said, "The export growth of other business divisions driven by the brand awareness of Rejuran in the second quarter is encouraging," adding, "It is necessary to assign a premium to the scalability of the Rejuran brand." He further analyzed, "At this stage, all business divisions are growing within diversified export countries, making it possible to apply a price-earnings ratio (PER) of 25 times."